Peculiarities of the antioxidant protection and nitrogen oxide systems of the brain in rats with experimental type 2 diabetes mellitus after carbacetam administration

Main Article Content

О.G. Kmet
S.V. Ziablitsev
N.D. Filipets


Background. The central nervous system (CNS) is one of the target organs for diabetes mellitus (DM). Hyperglycemic damages to the CNS are manifested with progres­sing cognitive disorders and decreased quality of life of patients. An important pathogenic link of DM and its complications is activation of the process of free radical biomolecule oxidation depending on the condition of GABA-ergic regulatory process. The purpose was to study the effect of carbacetam, a new modulator of GABA activity, on the state of the rat brain cortex and hippocampus prooxidant-antioxidant and oxide nitrogen (NO) systems in experimental type 2 DM. Materials and methods. The experiments were conducted on nonlinear laboratory albino male rats with the body weight of 0.18–0.20 kg with type 2 DM simulated by streptozotocin and high-fat diet. Carbacetam was introduced intraperitoneally at the dose of 5 mg/kg during 14 days. The intensity of lipid peroxide oxidation was estimated by the content of products reacting with 2-thiobarbituric acid. Antioxidant protection was evaluated by the activity of supero­xide dismutase (SOD) and catalase. The state of NO system was determined by the content of stable metabolites of nitrogen mo­noxide: nitrite-anions (NO2–) and NO-synthase (NOS) activity. Results. In the cerebral cortex and hippocampus of DM rats, the content of 2-thiobarbituric acid increased, and activity of SOD and catalase decreased. At the same time, NO2– content and NOS acti­vity increased in both structures. After administration of carbacetam, the content of 2-thiobarbituric acid decreased both in the cerebral cortex and hippocampus, and SOD activity increased in DM rats. Though catalase activity increased in the cerebral cortex, in the hippocampus this parameter is characte­rized by a tendency to increase only. NO2– content decreased in both examined structures. NO-synthase activity decreased after carbacetam administration in the hippocampus only. Conclusions. A correcting effect produced on the prooxidant-antioxidant balance and nitrogen oxide system in the cerebral cortex and hippocampus of rats is indicative of the neuroprotective properties of carbacetam in experimental type 2 DM.

Article Details

How to Cite
Kmet О., S. Ziablitsev, and N. Filipets. “Peculiarities of the Antioxidant Protection and Nitrogen Oxide Systems of the Brain in Rats With Experimental Type 2 Diabetes Mellitus After Carbacetam Administration”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 15, no. 5, Oct. 2019, pp. 376-80, doi:10.22141/2224-0721.15.5.2019.180040.
Original Researches


Acherjya G, Uddin MM, Chowdhury M, Srinivasan A. Central Nervous System Manifestations in Diabetes Mellitus - A Review. J Medicine. July 2017;18(2):109-112. doi: 10.3329/jom.v18i2.33689.

Zishan M, Ahmad Z, Idris S, Parveen Z, Hussain MW. Diabetes mellitus: role of free radicals and oxidative stress. World Journal of Pharmacy and Pharmaceutical Sciences. 2017;6(5):448-470. doi: 10.20959/wjpps20175-9135.

Ito F, Sono Y, Ito T. Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation. Antioxidants (Basel). 2019 Mar 25;8(3). pii: E72. doi: 10.3390/antiox8030072.

Hertz L. The Glutamate-Glutamine (GABA) Cycle: Importance of Late Postnatal Development and Potential Reciprocal Interactions between Biosynthesis and Degradation. Front Endocrinol (Lausanne). 2013 May 27;4:59. doi: 10.3389/fendo.2013.00059.

Schousboe A, Scafidi S, Bak LK, Waagepetersen HS, McKenna MC. Glutamate Metabolism in the Brain Focusing on Astrocytes. Adv Neurobiol. 2014;11:13-30. doi: 10.1007/978-3-319-08894-5_2.

Trujeque-Ramos S, Castillo-Rolón D, Galarraga E, et al. Insulin Regulates GABAA Receptor-Mediated Tonic Currents in the Prefrontal Cortex. Front Neurosci. 2018 May 31;12:345. doi: 10.3389/fnins.2018.00345.

Guo X, Wang Y, Wang K, Ji B, Zhou F. Stability of a type 2 diabetes rat model induced by high-fat diet feeding with low-dose streptozotocin injection. J Zhejiang Univ Sci B. 2018 Jul;19(7):559-569. doi: 10.1631/jzus.B1700254.

Jurgoński A, Juśkiewicz J, Zduńczyk Z. A high-fat diet differentially affects the gut metabolism and blood lipids of rats depending on the type of dietary fat and carbohydrate. Nutrients. 2014 Feb 3;6(2):616-26. doi: 10.3390/nu6020616.

Ang BRG, Yu GF. The Role of Fructose in Type 2 Diabetes and Other Metabolic Diseases. J Nutr Food Sci. 2018;8(1):659. doi: 10.4172/2155-9600.1000659.

Paxinos G, Watson Ch. The Rat Brain in Stereotaxic Coordinates. 7th Edition. Academic Press; 2013. 472 p.

Kushnir OYu, Yaremii IM, Shvets VI, Shvets NV. Influence of melatonin on glutathione system in rats skeletal muscle under alloxan induced diabetes. Fiziol Zh. 2018;64(5):54-62. doi: 10.15407/fz64.05.054.

Dubinina EE, Sal'nikova LA, Efimova LF. Activity and isoenzyme spectrum of human plasma and erythrocyte superoxide dismutase. Lab Delo. 1983;(10):30-3. (in Russian).

Koroliuk MA, Ivanova LI, Maĭorova IG, Tokarev VE. Method for determination of catalase activity. Lab Delo. 1988;(1):16-9. (in Russian).

Chekman ІS, Belenіchev ІF, Nagorna OO, et al. Preclinical study of the specific activity of potential primary and secondary neuroprotection drugs. Methodical Recommendations of the State Expert Center of the Ministry of Health of Ukraine. MH of Ukraine: Kyiv; 2016. 92 p. (in Ukrainian).

Ceban E, Banov P, Galescu A, Botnari V. Oxidative stress and antioxidant status in patients with complicate urolithiasis. J Med Life. 2016 Jul-Sep;9(3):259-262.

Ziablіcev SV, Starodubska OO, Dyadik OO. Carbacetam effect on processes of neurodestruction in hippocampus during experimental traumatic brain injury. Morphologia. 2017;11(2):12-18. doi: 10.26641/1997-9665.2017.2.12-18. (in Ukrainian).